Rebekah Waikel G'19 co-authored Herum K.M., Weng G., Kahnert K., Waikel R., Milburn G., Conger A., Anaya P., Campbell K.S., Lundby A., Won K.J., Brakebusch C. Cardiac fibroblast sub-types in vitro reflect pathological cardiac remodeling in vivo. Matrix Biol Plus. 15:100113 (2022).
Rebekah Waikel (class of 2019) co-authored Ledgister Hanchard, S.E., Dwyer, M.C., Liu, S., Hu, P., Tekendo-Ngongang, C., Waikel, R.L., Duong, D., Solomon, B.D. Scoping review and classification of deep learning in medical genetics. Genet Med. S1098-3600(22)00755-9 (2022).
Rebekah Waikel (class of 2019) co-authored Duong D., Hu P., Tekendo-Ngongang C., Ledgister Hanchard S., Liu S., Solomon B.D., Waikel R.L. Neural Networks for Classification and Image Generation of Aging in Genetic Syndromes. Front Genet. 13:864092 (2022).
"Even though I knew Genetic Counseling would touch on so many of my passions, a career change at 40 was very intimidating, and seemed impossible at times. But Bay Path's hybrid online program eliminated many logistical variables for a non-traditional student like me. The training has been excellent, and I landed the job of my dreams." - Page Brody G'19
"I graduated in 2019 as part of Bay Path University's inaugural class, and I currently work in telehealth. My primary area of practice is with the IVF/infertility sector, but I also regularly meet with hereditary cancer and prenatal patients. I have recently started a cardiogenetics clinic with my company, and we hope to see its volume grow in the coming months. I am proud of the work I have done thus far as a genetic counselor. I feel comfortable navigating psychologically intense content with patients, and I owe a great deal of that to Bay Path's strong foundation in psychology and counseling. Some people may never need a frame of reference for this, but fertility treatment is an incredible odyssey my patients are often thrown into. On the first day in the clinic, they typically collect about 12 tubes of blood, all sent off to different labs for different things. One of those tubes is typically sent off for carrier screening. I meet with couples to disclose those results, and talk about reproductive risk for recessive genetic disease. Oftentimes the patient I am meeting with has no idea what testing was even done, or for what reason. We live in this exciting time in history where our tools to mitigate genetic disease are largely still developing...but they exist. I speak with patients a lot about IVF embryo screening as a way to mitigate the risk for having a child with a particular genetic disease. It's incredible to think that we even have the capacity to do this, but the process is far from simple. A patient must be willing to journey through the process, which is both financially and physically draining. I think Bay Path really expanded my empathetic reach. It's not just about disclosing results in a way someone can understand. A large part of what we do is peeling back all of those social and psychological layers encasing a diagnosis. I am privileged to have the opportunity to serve as a guide for these patients at a time when we have some tools to prevent genetic disease, but not many to cure it. That is very difficult for people to navigate. It's really amazing for me to reflect on how many students Bay Path has already had and will have in the future. Students who will be genetic counselors like myself, and who will play such a pivotal role in so many lives. I thank Bay Path deeply for that." -Nicolette Lawrence, G'19